These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 14032230)

  • 1. [On the biological evaluation of coronary dilator agents].
    KHADZHAI IaI; CHERKASOVA IN
    Farmakol Toksikol; 1962; 25():573-8. PubMed ID: 14032230
    [No Abstract]   [Full Text] [Related]  

  • 2. [INVERSION OF THE CORONARY DILATOR EFFECT OF SOME DRUGS BY ERGOTAMINE TARTRATE].
    ESPLUGUES J; BRUGGER A; HUESO E; SOTO L
    Rev Esp Fisiol; 1963 Dec; 19():155-62. PubMed ID: 14165287
    [No Abstract]   [Full Text] [Related]  

  • 3. Relative experimental coronary vasodilator potencies and toxicities of papaverine, theophylline, and a papaverine-theophylline molecular association compound.
    WINDER CV; KAISER ME
    J Pharmacol Exp Ther; 1948 May; 93(1):86-92. PubMed ID: 18865189
    [No Abstract]   [Full Text] [Related]  

  • 4. Relative experimental coronary vasodilator potencies of papaverine and its ethyl analogue, ethaverine (diquinol, perparin).
    WINDER CV; THOMAS RW; KAMM O
    J Pharmacol Exp Ther; 1950 Dec; 100(4:1):482-8. PubMed ID: 14804286
    [No Abstract]   [Full Text] [Related]  

  • 5. Papaverine analogs. VII. Studies on the time of onset of coronary dilator action.
    HANNA C
    Arch Int Pharmacodyn Ther; 1959 Mar; 119(1-2):162-7. PubMed ID: 13628273
    [No Abstract]   [Full Text] [Related]  

  • 6. [Coronary dilator action of 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)pyrimidine: experimental coronary radiographic findings].
    ROVELLI F; BARBACCIA F; DISTANTE S; DONATELLI R
    Atti Soc Ital Cardiol; 1962; 22(2)():Comunicazioni 72-4. PubMed ID: 13982780
    [No Abstract]   [Full Text] [Related]  

  • 7. [Research on the benzofurans series. I. Benzofurans possessing coronary dilator activity].
    DELTOUR G; BINON F; HENAUX F; CHARLIER R
    Arch Int Pharmacodyn Ther; 1961 Apr; 131():84-106. PubMed ID: 13721708
    [No Abstract]   [Full Text] [Related]  

  • 8. Papaverine analogs. VI. Relationship between chemical structure and coronary vasodilator action.
    HANNA C; SHUTT JH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1953; 220(1-2):43-51. PubMed ID: 13132927
    [No Abstract]   [Full Text] [Related]  

  • 9. [On several derivatives of 2- and 4-(beta-phenlpropionyl)-phenoxyacetic acids with presumed coronary-dilator action].
    BRAMANTI G; DI PACO GF
    Boll Chim Farm; 1962 Oct; 101():796-808. PubMed ID: 14014910
    [No Abstract]   [Full Text] [Related]  

  • 10. [Spasmolytic and coronary dilator activities of some derivatives 3-ethyl chromone].
    BRADEL-GAY Y; GUIROY P; BOURILLET F
    Therapie; 1962; 17():1211-8. PubMed ID: 14014809
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of 3-(2-diethylaminoethyl)-4-methyl-7-carbethoxymethoxy-2-oxo-(1,2-chromene), a selective coronary dilator agent, on circulation, respiration and metabolism].
    BRETSCHNEIDER HJ; EBERLEIN HJ; KABUS HM; NELLE G; REICHMANN W
    Arzneimittelforschung; 1963 Apr; 13():255-68. PubMed ID: 14015321
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitory effects of coronary vasodilator papaverine on heterologously-expressed HERG currents in Xenopus oocytes.
    Kim CS; Lee N; Son SJ; Lee KS; Kim HS; Kwak YG; Chae SW; Lee SD; Jeon BH; Park JB
    Acta Pharmacol Sin; 2007 Apr; 28(4):503-10. PubMed ID: 17376289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papaverine as a coronary vasodilator.
    Mancini GB; McGillem MJ
    AJR Am J Roentgenol; 1986 Nov; 147(5):1095-6. PubMed ID: 3490157
    [No Abstract]   [Full Text] [Related]  

  • 14. Arterial endothelial denudation by intraluminal use of papaverine-NaCl solution in coronary bypass surgery.
    Mäyränpää M; Simpanen J; Hess MW; Werkkala K; Kovanen PT
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):560-6. PubMed ID: 15037272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Change in the action of the vagus nerve on the coronary vessels under the influence of vasodilator agents].
    SAMOILOVA ZT
    Farmakol Toksikol; 1962; 25():569-73. PubMed ID: 13991332
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of coronary dilator drugs].
    SETNIKAR I
    Farmaco Sci; 1956; 11(12):1018-21. PubMed ID: 13414868
    [No Abstract]   [Full Text] [Related]  

  • 17. [Observations on the evaluation of coronary dilator drugs].
    SETNIKAR I
    Farmaco Sci; 1956; 11(9):750-76. PubMed ID: 13414848
    [No Abstract]   [Full Text] [Related]  

  • 18. Internal thoracic artery response to papaverine: takes time.
    Barner HB
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):726; author reply 726-7. PubMed ID: 15784393
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative studies on the efficacy of commonly-used coronary vasodilator agents in anesthetized and unanesthetized dogs].
    DOERNER J; WICK E
    Arzneimittelforschung; 1960 Aug; 10():631-6. PubMed ID: 13723424
    [No Abstract]   [Full Text] [Related]  

  • 20. [Probable mechanism of action of coronary vasodilator drugs].
    CUERVO MUNOZ C
    Med Esp; 1963 May; 49():508-10. PubMed ID: 14024178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.